annual D&A:
$2.60M+$1.08M(+70.87%)Summary
- As of today (June 1, 2025), ARQT annual depreciation & amortization is $2.60 million, with the most recent change of +$1.08 million (+70.87%) on December 31, 2024.
- During the last 3 years, ARQT annual D&A has risen by +$2.15 million (+472.47%).
- ARQT annual D&A is now at all-time high.
Performance
ARQT Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$3.13M+$2.67M(+583.84%)Summary
- As of today (June 1, 2025), ARQT quarterly depreciation & amortization is $3.13 million, with the most recent change of +$2.67 million (+583.84%) on March 31, 2025.
- Over the past year, ARQT quarterly D&A has increased by +$2.77 million (+774.86%).
- ARQT quarterly D&A is now at all-time high.
Performance
ARQT quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$5.37M+$2.77M(+106.73%)Summary
- As of today (June 1, 2025), ARQT TTM depreciation & amortization is $5.37 million, with the most recent change of +$2.77 million (+106.73%) on March 31, 2025.
- Over the past year, ARQT TTM D&A has increased by +$3.86 million (+254.42%).
- ARQT TTM D&A is now at all-time high.
Performance
ARQT TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ARQT Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +70.9% | +774.9% | +254.4% |
| 3 y3 years | +472.5% | +1988.0% | +961.9% |
| 5 y5 years | +3722.1% | +10000.0% | +7467.6% |
ARQT Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +472.5% | at high | +1988.0% | at high | +961.9% |
| 5 y | 5-year | at high | +3722.1% | at high | >+9999.0% | at high | +7467.6% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% | at high | >+9999.0% |
ARQT Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $3.13M(+583.8%) | $5.37M(+106.7%) |
| Dec 2024 | $2.60M(+70.9%) | $458.00K(-68.0%) | $2.60M(+2.9%) |
| Sep 2024 | - | $1.43M(+308.0%) | $2.53M(+70.6%) |
| Jun 2024 | - | $351.00K(-2.0%) | $1.48M(-2.3%) |
| Mar 2024 | - | $358.00K(-7.0%) | $1.52M(-0.3%) |
| Dec 2023 | $1.52M(+62.8%) | $385.00K(-0.5%) | $1.52M(+2.6%) |
| Sep 2023 | - | $387.00K(+0.3%) | $1.48M(+7.6%) |
| Jun 2023 | - | $386.00K(+6.3%) | $1.38M(+20.1%) |
| Mar 2023 | - | $363.00K(+4.6%) | $1.15M(+22.8%) |
| Dec 2022 | $934.00K(+105.7%) | $347.00K(+23.0%) | $934.00K(+29.2%) |
| Sep 2022 | - | $282.00K(+81.9%) | $723.00K(+29.8%) |
| Jun 2022 | - | $155.00K(+3.3%) | $557.00K(+10.1%) |
| Mar 2022 | - | $150.00K(+10.3%) | $506.00K(+11.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $454.00K(+272.1%) | $136.00K(+17.2%) | $454.00K(+28.6%) |
| Sep 2021 | - | $116.00K(+11.5%) | $353.00K(+32.2%) |
| Jun 2021 | - | $104.00K(+6.1%) | $267.00K(+38.3%) |
| Mar 2021 | - | $98.00K(+180.0%) | $193.00K(+58.2%) |
| Dec 2020 | $122.00K(+79.4%) | $35.00K(+16.7%) | $122.00K(+9.9%) |
| Sep 2020 | - | $30.00K(0.0%) | $111.00K(+11.0%) |
| Jun 2020 | - | $30.00K(+11.1%) | $100.00K(+40.8%) |
| Mar 2020 | - | $27.00K(+12.5%) | $71.00K(+4.4%) |
| Dec 2019 | $68.00K(>+9900.0%) | $24.00K(+26.3%) | $68.00K(+54.5%) |
| Sep 2019 | - | $19.00K(+1800.0%) | $44.00K(+76.0%) |
| Jun 2019 | - | $1000.00(-95.8%) | $25.00K(+4.2%) |
| Mar 2019 | - | $24.00K | $24.00K |
| Dec 2018 | $0.00(0.0%) | - | - |
| Dec 2017 | $0.00 | - | - |
FAQ
- What is Arcutis Biotherapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics annual D&A year-on-year change?
- What is Arcutis Biotherapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics quarterly D&A year-on-year change?
- What is Arcutis Biotherapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics TTM D&A year-on-year change?
What is Arcutis Biotherapeutics annual depreciation & amortization?
The current annual D&A of ARQT is $2.60M
What is the all time high annual D&A for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high annual depreciation & amortization is $2.60M
What is Arcutis Biotherapeutics annual D&A year-on-year change?
Over the past year, ARQT annual depreciation & amortization has changed by +$1.08M (+70.87%)
What is Arcutis Biotherapeutics quarterly depreciation & amortization?
The current quarterly D&A of ARQT is $3.13M
What is the all time high quarterly D&A for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high quarterly depreciation & amortization is $3.13M
What is Arcutis Biotherapeutics quarterly D&A year-on-year change?
Over the past year, ARQT quarterly depreciation & amortization has changed by +$2.77M (+774.86%)
What is Arcutis Biotherapeutics TTM depreciation & amortization?
The current TTM D&A of ARQT is $5.37M
What is the all time high TTM D&A for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high TTM depreciation & amortization is $5.37M
What is Arcutis Biotherapeutics TTM D&A year-on-year change?
Over the past year, ARQT TTM depreciation & amortization has changed by +$3.86M (+254.42%)